APA (7th ed.) Citation

Drobni, Z. D., Michielin, O., Quinaglia, T., Zlotoff, D. A., Zubiri, L., Gilman, H. K., . . . Neilan, T. G. (2022). Renin–angiotensin–aldosterone system inhibitors and survival in patients with hypertension treated with immune checkpoint inhibitors. European Journal of Cancer, 163, 108. https://doi.org/10.1016/j.ejca.2021.12.024

Chicago Style (17th ed.) Citation

Drobni, Zsofia D., et al. "Renin–angiotensin–aldosterone System Inhibitors and Survival in Patients with Hypertension Treated with Immune Checkpoint Inhibitors." European Journal of Cancer 163 (2022): 108. https://doi.org/10.1016/j.ejca.2021.12.024.

MLA (9th ed.) Citation

Drobni, Zsofia D., et al. "Renin–angiotensin–aldosterone System Inhibitors and Survival in Patients with Hypertension Treated with Immune Checkpoint Inhibitors." European Journal of Cancer, vol. 163, 2022, p. 108, https://doi.org/10.1016/j.ejca.2021.12.024.